Skip to main content

Peer Review reports

From: SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients

Original Submission
10 Oct 2017 Submitted Original manuscript
13 Oct 2017 Author responded Author comments - Zhu Mei
Resubmission - Version 2
13 Oct 2017 Submitted Manuscript version 2
16 Nov 2017 Reviewed Reviewer Report - Qiang Li
17 Nov 2017 Reviewed Reviewer Report - Ashok Dilly
4 Dec 2017 Reviewed Reviewer Report - Zong Sheng Guo
13 Dec 2017 Author responded Author comments - Zhu Mei
Resubmission - Version 3
13 Dec 2017 Submitted Manuscript version 3
15 Dec 2017 Reviewed Reviewer Report - Qiang Li
20 Dec 2017 Reviewed Reviewer Report - Zong Sheng Guo
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
22 Mar 2018 Editorially accepted
27 Apr 2018 Article published 10.1186/s12885-018-4298-5

You can find further information about peer review here.

Back to article page